Laurelwood

OTHER NAME(S): Alexandrian-laurel, Alexandrinischer Lorbeer, Borneo-mahogany, Calanolide, Calophylle Inophyle, Calophylle Inophylle, Calophyllum Tree, Colophyllum Inophyllum, Huile de Tamanu, Indian-laurel, Kamani Punna, Laurier d'Alexandrie, Laurier Alexandrin, Mahogany, Oleum Calophyllum, Palo de Santa Maria, Palo Maria, Punnanga, Takamaka, Tamanu Oil, Temanu, Undi, Calophyllum inophyllum, Tamanu

Overview

Laurelwood is a plant. The nut and other plant parts are used to make medicine.

Don't confuse laurelwood (Calophyllum inophyllum) with blue cohosh (Caulophyllum thalictroides).

Laurelwood contains compounds that have been tested in the laboratory and seem to be somewhat effective against HIV. However, there isn't enough evidence to know if laurelwood works for medicinal uses in humans.

Laurelwood is used for leprosy, hemorrhoids, scabies, gonorrhea, vaginal infections, and chicken pox. It is also used for viral infections, such as HIV.

Tamanu oil from the nut of laurelwood is used for skin conditions including sunburn, rashes, burns, psoriasis, dermatitis, scratches, skin blemishes, acne, skin allergies, bedsores, rosacea, and hemorrhoids.

Laurelwood contains compounds that have been tested in the laboratory and seem to be somewhat effective against HIV. However, there isn't enough evidence to know if laurelwood works for medicinal uses in humans.

References
  1. Protocol Title: A Phase 1B Dose-Range Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-calaonlide A on surrogate markers in HIV-positive patients with no previous antiretroviral therapy. Protocol ID numbers: FDA 297A.
  2. Reuters Health. Anti-HIV herbal product shows therapeutic potential in phase I trial. November 1, 1999.
  3. Newman RA, Chen W, Madden TL. Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci 1998;87:1077-80.
  4. Buckheit RW, White EL, Fliakas-Boltz V, et al. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother 1999;43:1827-34.
  5. Boyer PL, Currens MH, McMahon JB. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J Virol 1993;67:2412-20.
  6. Currens MJ, Nariner JM, McMahon JB, Boyd MR. Kinetic analysis of inhibition of human immunodeficiency virus type-a reverse transcriptase by calanolide A. J Pharmacol Exp Ther 1996;279:652-61.
  7. Currens MJ, Gulakowski RJ, Mariner JM, et al. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1. J Pharmacol Exp Ther 1996;279:645-51.
  8. De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med.Res Rev. 2000;20(5):323-349.
  9. Itoigawa, M., Ito, C., Tan, H. T., Kuchide, M., Tokuda, H., Nishino, H., and Furukawa, H. Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum. Cancer Lett. 8-10-2001;169(1):15-19.
  10. Sekino, E., Kumamoto, T., Tanaka, T., Ikeda, T., and Ishikawa, T. Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+)-calanolide A by application of (-)-quinine-catalyzed intramolecular oxo-Michael addition. J Org Chem 4-16-2004;69(8):2760-2767.
  11. Laure, F., Herbette, G., Faure, R., Bianchini, J. P., Raharivelomanana, P., and Fogliani, B. Structures of new secofriedelane and friedelane acids from Calophyllum inophyllum of French Polynesia. Magn Reson.Chem 2005;43(1):65-68.
  12. Yimdjo, M. C., Azebaze, A. G., Nkengfack, A. E., Meyer, A. M., Bodo, B., and Fomum, Z. T. Antimicrobial and cytotoxic agents from Calophyllum inophyllum. Phytochemistry 2004;65(20):2789-2795.
  13. Le Coz, C. J. Allergic contact dermatitis from tamanu oil (Calophyllum inophyllum, Calophyllum tacamahaca). Contact Dermatitis 2004;51(4):216-217.
  14. Oku, H., Ueda, Y., Iinuma, M., and Ishiguro, K. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. Planta Med 2005;71(1):90-92.
  15. Potti, G. R. and Kurup, P. A. Antibacterial principle of the root bark of Calophyllum inophyllum: isolation and antibacterial activity. Indian J Exp.Biol. 1970;8(1):39-40.
  16. Patil, A. D., Freyer, A. J., Eggleston, D. S., Haltiwanger, R. C., Bean, M. F., Taylor, P. B., Caranfa, M. J., Breen, A. L., Bartus, H. R., Johnson, R. K., and . The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J Med Chem 12-24-1993;36(26):4131-4138.
  17. Taylor, P. B., Culp, J. S., Debouck, C., Johnson, R. K., Patil, A. D., Woolf, D. J., Brooks, I., and Hertzberg, R. P. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J Biol.Chem 3-4-1994;269(9):6325-6331.
  18. Spino, C., Dodier, M., and Sotheeswaran, S. Anti-HIV coumarins from Calophyllum seed oil. Bioorg.Med Chem Lett. 12-15-1998;8(24):3475-3478.
  19. Pillai, S. N., Desai, M. V., and Shah, H. M. Antihelminthic properties of Punnakkai Cake (Calophyllum inophyllum). Indian J Mycol Plant Path 1974;4(145):150.
  20. Adeyeye, A. Studies on seed oils of Garcinia kola and Calophyllum inophyllum. Journal Of The Science Of Food And Agriculture 1991;57(3):441-442.
  21. Hemavathy, J. and Prabhakar, J. V. Lipid composition of Calophyllum inophyllum kernel. Journal Of The American Oil Chemists' Society 1990;67(12):955-957.